{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Alanine aminotransferase > 3 × ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Aspartate aminotransferase > 3 × ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"}]}],"title":"Bilirubin > 1.5 × ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"8"}]}],"title":"Creatinine > 194 μmol/L"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11"}]}],"title":"Gamma glutamyl transferase > 2.5 × ULN"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Potassium < 3.0 mmol/L"},{"categories":[{"measurements":[{"groupId":"OG000","value":"20"}]}],"title":"Potassium > 5.5 mmol/L"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Sodium ≤ 130 mmol/L"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Sodium > 150 mmol/L"}],"denoms":[{"counts":[{"groupId":"OG000","value":"240"}],"units":"Participants"}],"description":"The number of patients with each type of event is summarized.","groups":[{"description":"6 once-weekly intravesical instillations of UGN-102 (75 mg mitomycin).","id":"OG000","title":"UGN-102"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All patients who received any dose of UGN-102 and who had a post-baseline laboratory value.","reportingStatus":"POSTED","timeFrame":"6 months","title":"Number of Participants With Post-baseline PCS Chemistry Values","type":"SECONDARY","unitOfMeasure":"Participants"}